Regulatory T cells;Regulacijski T-limfociti

Acta Medica Croatica

Volumn 60, Issue 5, 2006, Pages 447-456

  Marinić, Igor ^a,c   Gagro, Alenka ^a,b,c   Rabatić, Sabina ^a,c  

^a Imunološki Zavod ^*  (Croatia)

^b Odsjek za Celularnu Imunologiju   (Croatia)

^c INSTITUTE OF IMMUNOLOGY   (Croatia)

Author keywords

Allergy; Autoimmune disorders; Regulatory T cells

Indexed keywords

CD45RO ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; NOTCH RECEPTOR; PADGEM PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; CELL LINE; CELL PROLIFERATION; ENDOCRINE DISEASE; GENE MUTATION; HUMAN; IMMUNE RESPONSE; IPEX SYNDROME; PHENOTYPE; REGULATORY T LYMPHOCYTE; REVIEW; THYMUS;

HUMANS; T-LYMPHOCYTES, REGULATORY;

EID: 33845998965     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Sakaguchi S, Fukuma K, Kuribayashi K, Masuda T. Organ-specific autoimmune diseases induced in mice by elimination of T-cell subset. I. Evidence for the active participation of T cells in natural self-tolerance: deficit of a T-cell subset as a possible cause of autoimmune disease. J Exp Med 1985; 161: 72-87.
2. Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22: 531-62.
3. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-64.
4. Gambineri E, Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003; 15: 430-5.
5. Jordan MS, Boesteanu A, Reed AJ i sur. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immun 2001; 2: 301-6.
6. Hsieh CS, Liang Y, Tyznik AJ, Self SG, Liggitt D, Rudensky AY. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 2004; 21: 267-77.
7. Modigliani Y, Bandeira A, Coutinho A. A model for developmentally acquired thymus-dependent tolerance to central and peripheral antigens. Immunol Rev 1996; 149: 155-20.
8. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immun 2005; 6: 345-52.
9. Hawrylowicz CM, O'Garra A. Potential role of interleukin-10 secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 2005; 5: 271-83
10. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25high Regulatory Cells in Human Peripheral Blood. J Immunol 2001; 167: 1245-1253.
11. Cozzo C, Larkin J, Caton AJ. Self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells. J Immunol 2003; 171: 5678-5682.
12. Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immun 2005; 6: 353-60.
13. Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immun 2005; 6: 338-44.
14. Barrat FJ, Cua DJ, Boonstra A i sur. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002; 195: 603-16.
15. Mills KH. Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 2004; 4: 841-55.
16. Groux H. Generation of a novel regulatory CD4+ T-cell population, which inhibits antigen-specific T-cell responses. Nature 1997; 389: 737-742.
17. Levings MK, Sangregorio R, Galbiati F i sur. IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 2001; 166: 5530-5539.
18. Weiner HL. Induction and mechanism of action of transforming growth fartor-α-secreting Th3 regulatory cells. Immunol Rev 2001; 182: 207-214.
19. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994; 265: 1237-40.
20. Levings MK, Sangregorio R, Sartirana C i sur. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med 2002; 196: 1335-46.
21. O'Garra A, Vieira PL, Vieira P, Goldfeld AE. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest 2004; 114: 1372-8.
22. Sonoda KH, Faunce DE, Taniguchi M, Exley M, Balk S, Stein-Streilein J. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J Immunol 2001; 166: 42-50.
23. Bendelac A, Rivera MN, Park SH, Roark JH. Mouse CD1-specific NK1 T cells: development, specificity and function. Annu Rev Immunol 1997; 15: 535-62.
24. Bendelac A, Lantz O, Quimby ME, Yewdell JW, Bennink JR, Brutkiewicz RR. CD1 recognition by mouse NK1+ T lymphocytes. Science 1995; 268: 863-5.
25. Sharif S, Arreaza GA, Zucker P, Delovitch TL. Regulatory natural killer T cells protect against spontaneous and recurrent type 1 diabetes. Ann N Y Acad Sci 2002; 958: 77-88.
26. D'Orazio TJ, Niederkorn JY. A novel role for TGF-beta and IL-10 in the induction of immune privilege. J Immunol 1998; 160: 2089-98.
27. Takahashi T, Kuniyasu Y, Toda M i sur. Immunologic self-tolerance maintained by CD25+ CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998; 10: 1969-80.
28. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188: 287-96.
29. Paust S, Lu L, McCarty N, Cantor H. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci U S A 2004; 101: 10398-403.
30. Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 2004; 4: 762-74.
31. Shevach EM. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002; 2: 389-400.
32. Taams LS, Vukmanovic-Stejic M, Smith J i sur. Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur J Immunol 2002; 32: 1621-30.
33. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057-61.
34. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immun 2003; 4: 330-6.
35. Bettelli E, Dastrange M, Oukka M. Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci U S A 2005; 102: 5138-43.
36. Tommasini A, Ferrari S, Moratto D i sur. X-chromosome inactivarion analysis in a female carrier of FOXP3 mutation. Clin Exp Immunol 2002; 130: 127-30.
37. Walunas TL, Lenschow DJ, Bakker CY i sur. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994; 1: 405-413.
38. Bour-Jordan H, Bluestone JA. T-cell mediated immunity U: Janeway CA, Travers P, Walport M, Shlomchik MJ, Immunobiology - the immune system in health and disease. New York: 6th edition. Garland Science Publishing, 2005, 328-31.
39. Waterhouse P, Penninger JM, Timms E i sur. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 1995; 270: 985-988.
40. Kim JD, Choi BK, Bae JS i sur. Cloning and characterization of GITR ligand. Genes Immun 2003; 4: 564-9.
41. Stephens GL, McHugh RS, Whitters MJ i sur. Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J Immunol 2004; 173: 5008-20.
42. Gavin MA, Clarke SR, Negrou E, Gallegos A, Rudensky A. Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo. Nat Immun 2002; 3: 33-41.
43. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance. Nat Immun 2002; 3: 135-42.
44. McHugh RS, Whitters MJ, Piccirillo CA i sur. CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002; 16: 311-23.
45. Ji HB, Liao G, Faubion WA, Abadia-Molina AC i sur. Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression. J Immunol 2004; 172: 5823-7.
46. Nocentini G, Riccardi C. GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur J Immunol 2005; 35: 1016-22.
47. Tone M, Tone Y, Adams E i sur. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is co-stimulatory for T cells. Proc Natl Acad Sci. U S A 2003; 100: 15059-15064.
48. Yu KY, Kim HS, Song SY, Min SS, Jeong JJ, Youn BS. Identification of a ligand for glucocorticoid-induced tumor necrosis factor receptor constitutively expressed in dendritic cells. Biochem Biophys Res Commun 2003; 310: 433-438.
49. Okazaki T, Iwai Y, Honjo T. New regulatory coreceptors: inducible co-stimulator and PD-1. Curr Opin Immunol 2002; 14: 779-82.
50. Anastasi E, Campese AF, Bellavia D i sur. Expression of activated Notch3 in transgenic mice enhances generation of T regulatory cells and protects against experimental autoimmune diabetes. J Immunol 2003; 171: 4504-11.
51. Ishida Y, Agata Y, Shibahara K, Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 1992; 11: 3887-95.
52. Agata Y, Kawasaki A, Nishimura H i sur. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 1996; 8: 765.
53. Freeman GJ, Long AJ, Iwai Y i sur. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000; 192: 1027.
54. Bennett F, Luxenberg D, Ling V i sur. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses. J Immunol 2003; 170: 711-8.
55. Anderson G, Moore NC, Owen JJT, Jenkinson EJ. Signaling through immune system receptors. U: Janeway CA, Travers P, Walport M, Shlomchik MJ. Immunobiology - the immune system in health and disease. 6th edition. New York: Garland Science Publishing, 2005, 251-2.
56. Yvon ES, Vigouroux S, Rousseau RF i sur. Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells. Blood 2003; 102: 3815-21.
57. Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perform pathway to cause autologous target cell death. Immunity 2004; 21: 589-601.
58. Bennett CL, Christie J, Ramsdell F i sur. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27: 20-1.
59. Ehrenstein MR, Evans JG, Singh A i sur. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 2004; 200: 277-85.
60. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199: 971-9.
61. Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, Tree TI. Defective suppressor function in CD4+CD25+ T-cells from patients with type 1 diabetes. Diabetes 2005; 54: 92-9.
62. Ling EM, Smith T, Nguyen XD i sur. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004; 363: 608-15.
63. Cavani A, Nasorri F, Ottaviani C, Sebastiani S, De Pita O, Girolomoni G. Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals. J Immunol 2003; 171: 5760-8.
64. Aubin F, Mousson C. Ultraviolet light-induced regulatory (suppressor) T cells: an approach for promoting induction of operational allograft tolerance? Transplantation 2004; 77 (1 Suppl): S29-31.
65. Karlsson MR, Rugtveit J, Brandtzaeg P. Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 2004; 199: 1679-88.
66. MacDonald AJ, Duffy M, Brady MT i sur. CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J Infect Dis 2002; 185: 720-727.
67. Brady MT, MacDonald AJ, Rowan AG, Mills KH. Hepatitis C virus non-structural protein 4 suppresses TH1 responses by stimulating IL-10 production from monocytes. Eur J Immunol 2003; 33: 3448-3457.
68. Sewnath ME, Olszyna DP, Birjmohun R, ten Kate FJ, Gouma DJ, van Der Poll T. IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance. J Immunol 2001; 166: 6323-6331.
69. Higgins SC, Lavelle EC, McCann C i sur. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J Immunol 2003; 171; 3119-3127.
70. Hori S, Carvalho TL, Demengeot J. CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur J Immunol 2002; 32; 1282-1291.
71. Montagnoli C, Bacci A, Bozza S i sur.. B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J Immunol 2002; 169: 6298-6308.
72. Netea MG, Sutmuller R, Hermann C i sur. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol 2004; 172: 3712-3718.
73. Hesse M, Piccirillo CA, Belkaid Y i sur. The pathogenesis of schistosomiasis is controlled by cooperating IL-10 producing innate effector and regulatory T cells. J Immunol 2004; 172: 3157-3166.
74. Redpath S, Ghazal P, Gascoigne NR. Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol 2001; 9: 86-92.
75. McGuirk P, Mills KH. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol 2002; 23: 450-5.
76. Marshall NA, Vickers MA, Barker RN. Regulatory T cells secreting IL-10 dominate the immune response to EBV latent membrane protein 1. J Immunol 2003; 170: 6183-6189.
77. Boussiotis VA, Tsai EY, Yunis EJ i sur. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 2000; 105: 1317-1325.
78. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420: 502-507.
79. Ostrowski MA, Gu JX, Kovacs C, Freedman J, Luscher MA, MacDonald KS. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1) - specific CD4+ T cell immunity to gag in HTV-1 infected individuals with differential disease progression: reciprocal interferon-γ and interleukin-10 responses. J Infect Dis 2001; 184: 1268-1278.
80. Kinter AL, Hennessey M, Bell A i sur. CD25+CD4+ regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4+ and CD8+ HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 2004; 200: 331-343.
81. Aandahl EM, Michaelsson J, Moretto WJ, Hecht FM, Nixon DF. Human CD4+CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 2004; 78: 2454-2459.
82. Nielsen J, Holm TL, Claesson MH. CD4+CD25+ regulatory T cells: II. Origin, disease models and clinical aspects. APMIS 2004; 112: 642-50.
83. Shimizu J, Yamazaki S, Sakaguchi S. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 1999; 163: 5211-8.
84. Sutmuller RP, van Duivenvoorde LM, van Elsas A i sur. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 2001; 194: 823-32.
85. Gregg R, Smith CM, Clark FJ i sur. The number of human peripheral blood CD4+ CD25 high regulatory T cells increases with age. Clin Exp Immunol 2005; 140: 540-6.
86. Bluestone JA. Regulatory T-cell therapy: is it ready for the clinic? Nat Rev Immunol 2005; 5: 343-9.
87. Levings MK, Sangregorio R, Roncarolo MG. Human CD25+CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001; 193: 1295-302.
88. Walker LS, Chodos A, Eggena M, Dooms H, Abbas AK. Antigen-dependent proliferation of CD44+ CD25+ regulatory T cells in vivo. J Exp Med 2003; 198: 249-58.
89. Karagiannidis C, Akdis M, Holopainen P i sur. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004; 114: 1425-33.